Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone. Thank you for joining today as Emergent discusses their operational and financial results for the second quarter of 2025. As is customary, today's call is open to all participants. The call is being recorded and is copyrighted by Emergent Biosolutions. In addition to today's press release, there are a series of slides accompanying this webcast available to all webcast participants. Turning to slide two. During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects, or future performance. These forward-looking statements are based on their current intentions, beliefs, and expectations regarding future events. Any forward-looking statement speaks only as of the date of this conference call and except as required by law, Emergent does not undertake to update any forward-looking statement to reflect new information, events, or circumstances. Investors should consider this cautionary statement as well as the risk factors identified in Emergent's periodic reports filed with the SEC when evaluating their forward-looking statements. During today's call, Emergent may also discuss certain non-GAAP financial measures that involve adjustments to GAAP figures in order to provide greater transparency regarding Emergent's operating performance. Please refer to the tables found in today's press release. Turning to slide three. The agenda for today's call will include Joe Papa, President and Chief Executive Officer, who will provide an update on the company's transformation plan and highly key results, and Rich Lindahl, EVP and Chief Financial Officer, who will provide details on the second quarter and -to-date 2025 financial results as well as provide an update on full year ...